Corneal crosslinking for progressive keratoconus in four children

Area of Science:

• Ophthalmology
• Corneal Surgery
• Pediatric Eye Care

Background:

• Keratoconus is a progressive eye condition causing thinning and bulging of the cornea.
• Current guidelines restrict corneal crosslinking (CXL) to patients aged 18 and older.
• Rapid progression of keratoconus in teenagers necessitates alternative treatment strategies.

Observation:

• This study details four pediatric cases of progressive keratoconus.
• All patients underwent corneal crosslinking (CXL) for treatment.
• The procedure was evaluated for safety and efficacy in this young demographic.

Findings:

• Corneal crosslinking (CXL) demonstrated a safe and effective treatment option for pediatric keratoconus.
• The treatment successfully halted disease progression in the observed cases.
• No significant adverse events were reported during or after the CXL procedure.

Implications:

• Corneal crosslinking (CXL) may be a viable option for younger keratoconus patients.
• Early intervention with CXL could prevent the need for corneal transplantation in adolescents.
• This approach could significantly improve long-term visual outcomes for pediatric keratoconus patients.